论文信息 - Treatment of restless legs syndrome/Willis-Ekbom disease with the non-selective ENT1/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis. - 字舞流文

Treatment of restless legs syndrome/Willis-Ekbom disease with the non-selective ENT1/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis.

S. Ferré | D. Garcia-Borreguero | X. Guitart | J. Granizo | I. Cano-Pumarega | Celia García Malo